| Identification | More | [Name]
Diglycidyl 1,2-cyclohexanedicarboxylate | [CAS]
5493-45-8 | [Synonyms]
1,2-CYCLOHEXANEDICARBOXYLIC ACID DIGLYCIDYL ESTER
DIGLYCIDYL 1,2-CYCLOHEXANEDICARBOXYLATE
DIGLYCIDYL HEXAHYDROPHTHALATE
1,2-cyclohexanedicarboxylicacid,bis(2,3-epoxypropyl)ester
1,2-cyclohexanedicarboxylicacid,bis(oxiranylmethyl)-
1,2-Cyclohexanedicarboxylicacid,bis(oxiranylmethyl)ester
cyclohexane-1,2-dicarboxylicacidbis(oxiranylmethyl)ester
diglycidylesterkyselinyhexahydroftalove
diglycidylesterofhexahydrophthalicacid
hexahydro-phthalicacidiglycidylester
lekutherm2159
lekuthermx100
phthalicacid,hexahydro-,bis(2,3-epoxypropyl)ester
bis(2,3-epoxypropyl) cyclohexane-1,2-dicarboxylate
ORTHO-DIGLYCIDYLHEXAHYDROPHTHALATE
1,2-CYCLOHEXANEDICARBOXYLICACID,BIS(2,3-EPOXYPROPYL)EST.
HEXAHYDROPHTHALICACIDDIGLYCIDYLESTER
Bis(2,3-epoxypropyl)cyclohexan-1,2-dicarboxylat
Hexahydrophthalic acid diglycidyl ether
1,2-CYCLOHEXANEDICARBOXYLIC ACID DIGLYCIDYL ESTER 93+% | [EINECS(EC#)]
226-826-3 | [Molecular Formula]
C14H20O6 | [MDL Number]
MFCD00128914 | [Molecular Weight]
284.3 | [MOL File]
5493-45-8.mol |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin .
R43:May cause sensitization by skin contact. | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36:Wear suitable protective clothing . | [WGK Germany ]
1
| [RTECS ]
GU9070000
| [HS Code ]
29172090 |
| Hazard Information | Back Directory | [General Description]
Clear yellow viscous liquid. | [Reactivity Profile]
1,2-CYCLOHEXANEDICARBOXYLIC ACID, BIS(OXIRANYLMETHYL)-(5493-45-8) is incompatible with strong oxidizers, acids and alkalis. | [Air & Water Reactions]
Insoluble in water. | [Fire Hazard]
This chemical is combustible. | [Chemical Properties]
Colorless or light yellow liquid | [Uses]
It is used in epoxy-based industrial coatings and paints. | [Carcinogenicity]
HPADGE was tested in vitro for
gene mutation effects in S. typhimurium at concentrations up
to 231 mg/mL and was positive in strains TA100 and
TA1535. HPADGE has also been reported as positive
in the mouse lymphoma assay. Negative results were
found in the BALB/3T3 fibroblast transformation assay
at concentrations up to 30 mg/mL. In vivo,
HPADGE administered orally in a single dose of 1250,
2500, or 5000 mg/kg to Chinese hamsters produced a statistically
significant increase in SCEs in bone marrow cells
at the two higher dose levels. Mice given a single oral
dose of 500 or 1000 mg/kg had a statistically significant
increase in the frequency of micronucleated polychromatic
erythrocytes compared to negative controls. |
|
|